Investigating Participation Patterns Among Stage IV Melanoma Patients

Starting soon

Conditions studied: Stage IV Melanoma

In brief

Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Key facts

Study ID

NCT06093594

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-11-01

Expected to finish

2026-11-01

Last updated by the study team

2023-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥ 18 years old
• Diagnosis of stage IV melanoma
• Able to comprehend the investigational nature of the protocol and provide informed consent

You may not qualify if…

• Female patients who are currently pregnant or nursing
• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
• Inability to perform regular electronic reporting

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.